Immunofluorescence staining for CD3, used to detect tumor-infiltrating CAR-T cells, demonstrated that RLN2-secreting CAR-T cells were present not only in the stroma but also around the cancer cells within the tumor clusters. This evidence concerns the gene RLN2 and neoplasm.